TipRanks
Zymeworks Inc (DE:ZA8)
FRANKFURT:ZA8
Germany Market
ZA8
Zymeworks
RESEARCH TOOLSreports

Zymeworks (ZA8) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

ZA8 Analyst Ratings

Strong Buy
13Ratings
Strong Buy
13 Buy
0 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Zymeworks
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ZA8 Stock 12 Month Forecast

Average Price Target

€36.43
▲(59.65% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Zymeworks in the last 3 months. The average price target is €36.43 with a high forecast of €49.07 and a low forecast of €29.44. The average price target represents a 59.65% change from the last price of €22.82.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"13":"€13","50":"€50","22.25":"€22.3","31.5":"€31.5","40.75":"€40.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":49.0720912,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€49.07</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.43231013333334,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€36.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29.44325472,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€29.44</span>\n  </div></div>","useHTML":true}}],"tickPositions":[13,22.25,31.5,40.75,50],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.69,24.71939163076923,26.748783261538463,28.778174892307696,30.807566523076925,32.836958153846155,34.86634978461539,36.89574141538462,38.925133046153846,40.954524676923086,42.98391630769231,45.01330793846154,47.04269956923078,{"y":49.0720912,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.69,23.74710077948718,24.804201558974363,25.86130233846154,26.91840311794872,27.9755038974359,29.03260467692308,30.08970545641026,31.14680623589744,32.203907015384615,33.2610077948718,34.31810857435898,35.37520935384616,{"y":36.43231013333334,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.69,23.209481132307694,23.728962264615387,24.24844339692308,24.76792452923077,25.28740566153846,25.806886793846154,26.326367926153846,26.84584905846154,27.365330190769228,27.884811323076924,28.404292455384613,28.923773587692306,{"y":29.44325472,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.1,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.8,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.2,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.6,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.1,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.25,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.94,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.3,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.265,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.42,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.69,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€49.07Average Price Target€36.43Lowest Price Target€29.44
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on DE:ZA8
Gregory Renza
Truist Financial
Truist Financial
€28.55→€30.34
Buy
32.93%
Upside
Reiterated
10/07/26
Zymeworks price target raised to $34 from $32 at TruistZymeworks price target raised to $34 from $32 at Truist
Jefferies Analyst forecast on DE:ZA8
Unknown Analyst
Jefferies
Not Ranked
Jefferies
€38.37→€44.61
Buy
95.49%
Upside
Reiterated
09/29/26
Jefferies Remains a Buy on Zymeworks (ZYME)
TD Cowen Analyst forecast on DE:ZA8
Yaron Werber
TD Cowen
TD Cowen
€30.34
Buy
32.93%
Upside
Initiated
09/29/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Citi Analyst forecast on DE:ZA8
Yigal Nochomovitz
Citi
Citi
€33.9→€34.8
Buy
52.48%
Upside
Reiterated
09/29/26
Zymeworks price target raised to $39 from $38 at CitiZymeworks price target raised to $39 from $38 at Citi
Evercore ISI Analyst forecast on DE:ZA8
Jonathan Miller
Evercore ISI
Evercore ISI
€39.26
Buy
72.03%
Upside
Reiterated
09/29/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
LifeSci Capital Analyst forecast on DE:ZA8
Charles Zhu
LifeSci Capital
LifeSci Capital
€30.34
Buy
32.93%
Upside
Reiterated
09/28/26
Charles Zhu Reiterates Buy on Zymeworks, Keeps $34 Price Target After TBPH Acquisition Boosts Growth and Cash Flow Outlook
Wolfe Research Analyst forecast on DE:ZA8
Kalpit Patel
Wolfe Research
Wolfe Research
―
Buy
―
Initiated
09/17/26
Zymeworks initiated with an Outperform at Wolfe ResearchZymeworks initiated with an Outperform at Wolfe Research
J.P. Morgan Analyst forecast on DE:ZA8
Brian Cheng
J.P. Morgan
J.P. Morgan
€27.66→€29.44
Buy
29.02%
Upside
Reiterated
09/03/26
Zymeworks price target raised to $33 from $31 at JPMorganZymeworks price target raised to $33 from $31 at JPMorgan
H.C. Wainwright Analyst forecast on DE:ZA8
Robert Burns
H.C. Wainwright
H.C. Wainwright
€45.5→€49.07
Buy
115.04%
Upside
Reiterated
08/26/26
Zymeworks price target raised to $55 from $51 at H.C. WainwrightZymeworks price target raised to $55 from $51 at H.C. Wainwright
Bloom Burton Analyst forecast on DE:ZA8
David Martin PhD
Bloom Burton
Bloom Burton
€32.12→€33.01
Buy
44.66%
Upside
Reiterated
08/26/26
Analysts Offer Insights on Healthcare Companies: Zymeworks (NASDAQ: ZYME), Revolution Medicines (NASDAQ: RVMD) and Agilent (NYSE: A)
Wells Fargo Analyst forecast on DE:ZA8
Eva Fortea Verdejo
Wells Fargo
Wells Fargo
€35.69
Buy
56.39%
Upside
Assigned
08/25/26
Analysts Are Bullish on These Healthcare Stocks: Zymeworks (ZYME), Johnson & Johnson (JNJ)
Stifel Nicolaus Analyst forecast on DE:ZA8
Stephen Willey
Stifel Nicolaus
Stifel Nicolaus
€41.04
Buy
79.85%
Upside
Reiterated
08/11/26
Analysts Offer Insights on Healthcare Companies: Zymeworks (NASDAQ: ZYME) and Edgewise Therapeutics (NASDAQ: EWTX)
B. Riley Securities Analyst forecast on DE:ZA8
Mayank Mamtani
B. Riley Securities
B. Riley Securities
€35.69→€39.26
Buy
72.03%
Upside
Reiterated
08/10/26
Zymeworks price target raised to $44 from $40 at B. RileyZymeworks price target raised to $44 from $40 at B. Riley
Truist Financial Analyst forecast on DE:ZA8
Asthika Goonewardene
Truist Financial
Truist Financial
€35.69
Buy
56.39%
Upside
Reiterated
03/03/26
Truist Financial Keeps Their Buy Rating on Zymeworks (ZYME)
Citizens JMP Analyst forecast on DE:ZA8
Reni Benjamin
Citizens JMP
Citizens JMP
€28.55
Buy
25.11%
Upside
Initiated
12/03/25
Zymeworks initiated with an Outperform at Citizens JMPZymeworks initiated with an Outperform at Citizens JMP
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on DE:ZA8
Gregory Renza
Truist Financial
Truist Financial
€28.55→€30.34
Buy
32.93%
Upside
Reiterated
10/07/26
Zymeworks price target raised to $34 from $32 at TruistZymeworks price target raised to $34 from $32 at Truist
Jefferies Analyst forecast on DE:ZA8
Unknown Analyst
Jefferies
Not Ranked
Jefferies
€38.37→€44.61
Buy
95.49%
Upside
Reiterated
09/29/26
Jefferies Remains a Buy on Zymeworks (ZYME)
TD Cowen Analyst forecast on DE:ZA8
Yaron Werber
TD Cowen
TD Cowen
€30.34
Buy
32.93%
Upside
Initiated
09/29/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Citi Analyst forecast on DE:ZA8
Yigal Nochomovitz
Citi
Citi
€33.9→€34.8
Buy
52.48%
Upside
Reiterated
09/29/26
Zymeworks price target raised to $39 from $38 at CitiZymeworks price target raised to $39 from $38 at Citi
Evercore ISI Analyst forecast on DE:ZA8
Jonathan Miller
Evercore ISI
Evercore ISI
€39.26
Buy
72.03%
Upside
Reiterated
09/29/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
LifeSci Capital Analyst forecast on DE:ZA8
Charles Zhu
LifeSci Capital
LifeSci Capital
€30.34
Buy
32.93%
Upside
Reiterated
09/28/26
Charles Zhu Reiterates Buy on Zymeworks, Keeps $34 Price Target After TBPH Acquisition Boosts Growth and Cash Flow Outlook
Wolfe Research Analyst forecast on DE:ZA8
Kalpit Patel
Wolfe Research
Wolfe Research
―
Buy
―
Initiated
09/17/26
Zymeworks initiated with an Outperform at Wolfe ResearchZymeworks initiated with an Outperform at Wolfe Research
J.P. Morgan Analyst forecast on DE:ZA8
Brian Cheng
J.P. Morgan
J.P. Morgan
€27.66→€29.44
Buy
29.02%
Upside
Reiterated
09/03/26
Zymeworks price target raised to $33 from $31 at JPMorganZymeworks price target raised to $33 from $31 at JPMorgan
H.C. Wainwright Analyst forecast on DE:ZA8
Robert Burns
H.C. Wainwright
H.C. Wainwright
€45.5→€49.07
Buy
115.04%
Upside
Reiterated
08/26/26
Zymeworks price target raised to $55 from $51 at H.C. WainwrightZymeworks price target raised to $55 from $51 at H.C. Wainwright
Bloom Burton Analyst forecast on DE:ZA8
David Martin PhD
Bloom Burton
Bloom Burton
€32.12→€33.01
Buy
44.66%
Upside
Reiterated
08/26/26
Analysts Offer Insights on Healthcare Companies: Zymeworks (NASDAQ: ZYME), Revolution Medicines (NASDAQ: RVMD) and Agilent (NYSE: A)
Wells Fargo Analyst forecast on DE:ZA8
Eva Fortea Verdejo
Wells Fargo
Wells Fargo
€35.69
Buy
56.39%
Upside
Assigned
08/25/26
Analysts Are Bullish on These Healthcare Stocks: Zymeworks (ZYME), Johnson & Johnson (JNJ)
Stifel Nicolaus Analyst forecast on DE:ZA8
Stephen Willey
Stifel Nicolaus
Stifel Nicolaus
€41.04
Buy
79.85%
Upside
Reiterated
08/11/26
Analysts Offer Insights on Healthcare Companies: Zymeworks (NASDAQ: ZYME) and Edgewise Therapeutics (NASDAQ: EWTX)
B. Riley Securities Analyst forecast on DE:ZA8
Mayank Mamtani
B. Riley Securities
B. Riley Securities
€35.69→€39.26
Buy
72.03%
Upside
Reiterated
08/10/26
Zymeworks price target raised to $44 from $40 at B. RileyZymeworks price target raised to $44 from $40 at B. Riley
Truist Financial Analyst forecast on DE:ZA8
Asthika Goonewardene
Truist Financial
Truist Financial
€35.69
Buy
56.39%
Upside
Reiterated
03/03/26
Truist Financial Keeps Their Buy Rating on Zymeworks (ZYME)
Citizens JMP Analyst forecast on DE:ZA8
Reni Benjamin
Citizens JMP
Citizens JMP
€28.55
Buy
25.11%
Upside
Initiated
12/03/25
Zymeworks initiated with an Outperform at Citizens JMPZymeworks initiated with an Outperform at Citizens JMP
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
OVIDOvid Therapeutics
ASNDAscendis Pharma
QNCXQuince Therapeutics
EHCEncompass Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zymeworks

3 Months
Charles ZhuLifeSci Capital
Success Rate
13/17 ratings generated profit
76%
Average Return
+15.15%
Copying Charles Zhu's trades and holding each position for 3 Months would result in 76.47% of your transactions generating a profit, with an average return of +15.15% per trade.
1 Year
Charles ZhuLifeSci Capital
Success Rate
15/17 ratings generated profit
88%
Average Return
+44.01%
Copying Charles Zhu's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +44.01% per trade.
2 Years
Charles ZhuLifeSci Capital
Success Rate
15/17 ratings generated profit
88%
Average Return
+47.24%
Copying Charles Zhu's trades and holding each position for 2 Years would result in 88.24% of your transactions generating a profit, with an average return of +47.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZA8 Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
9
5
12
11
10
Buy
15
14
17
15
15
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
24
19
29
26
25
In the current month, ZA8 has received 25 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ZA8 average Analyst price target in the past 3 months is 36.43.
Each month's total comprises the sum of three months' worth of ratings.

ZA8 Financial Forecast

ZA8 Earnings Forecast

Next quarter’s earnings estimate for ZA8 is €2.04 with a range of -€0.51 to €2.93. The previous quarter’s EPS was -€0.55. ZA8 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ZA8 has Performed in-line its overall industry.
Next quarter’s earnings estimate for ZA8 is €2.04 with a range of -€0.51 to €2.93. The previous quarter’s EPS was -€0.55. ZA8 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ZA8 has Performed in-line its overall industry.

ZA8 Sales Forecast

Next quarter’s sales forecast for ZA8 is €202.46M with a range of €3.71M to €228.26M. The previous quarter’s sales results were €4.09M. ZA8 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ZA8 has Performed in-line its overall industry.
Next quarter’s sales forecast for ZA8 is €202.46M with a range of €3.71M to €228.26M. The previous quarter’s sales results were €4.09M. ZA8 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ZA8 has Performed in-line its overall industry.

ZA8 Stock Forecast FAQ

What is DE:ZA8’s average 12-month price target, according to analysts?
Based on analyst ratings, Zymeworks Inc’s 12-month average price target is 36.43.
    What is DE:ZA8’s upside potential, based on the analysts’ average price target?
    Zymeworks Inc has 59.65% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Zymeworks Inc a Buy, Sell or Hold?
          Zymeworks Inc has a consensus rating of Strong Buy, which is based on 13 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Zymeworks Inc’s share price target?
            The average share price target for Zymeworks Inc is 36.43. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €49.07 ,and the lowest forecast is €29.44. The average share price target represents 59.65% Increase from the current price of €22.82.
              What do analysts say about Zymeworks Inc?
              Zymeworks Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of Zymeworks Inc?
                To buy shares of DE:ZA8, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.